RxSight, Inc.
RXST
$8.43
$0.212.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.29% | 40.34% | 43.52% | 44.23% | 38.14% |
| Total Depreciation and Amortization | -22.74% | -25.43% | -14.59% | 1.58% | 5.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -99.30% |
| Total Other Non-Cash Items | 48.06% | 37.19% | 39.27% | 30.22% | 43.10% |
| Change in Net Operating Assets | 21.02% | -79.98% | -1.53% | -15.04% | -19.92% |
| Cash from Operations | 43.22% | 50.30% | 59.26% | 55.49% | 45.51% |
| Capital Expenditure | 29.16% | 32.91% | -13.00% | -72.50% | -63.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 149.58% | -274.52% | -442.14% | -607.45% | -116.31% |
| Cash from Investing | 139.65% | -303.39% | -348.78% | -489.72% | -110.67% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | 99.81% | 99.92% | 99.90% | 99.86% | 49.91% |
| Issuance of Common Stock | -93.13% | 137.98% | 21.67% | 18.81% | 46.61% |
| Repurchase of Common Stock | -25.87% | -25.87% | -235.14% | -235.75% | -421.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.09% | 70.77% | 73.12% | 76.17% | 38.48% |
| Cash from Financing | -95.48% | 2,621.25% | 100.44% | 92.79% | 59.33% |
| Foreign Exchange rate Adjustments | 1,600.00% | -100.00% | -250.00% | -8.33% | -112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -200.00% | -- |
| Net Change in Cash | 1.95% | -121.34% | 421.76% | 711.23% | 202.24% |